Pictet Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159M | Buy |
304,127
+3,171
| +1% | +$1.66M | 0.16% | 146 |
|
|
2025
Q1 | $191M | Buy |
300,956
+86,859
| +41% | +$55.2M | 0.21% | 120 |
|
|
2024
Q4 | $153M | Sell |
214,097
-72,448
| -25% | -$51.6M | 0.16% | 152 |
|
|
2024
Q3 | $300M | Sell |
286,545
-7,219
| -2% | -$7.57M | 0.33% | 78 |
|
|
2024
Q2 | $309M | Sell |
293,764
-110,480
| -27% | -$116M | 0.35% | 68 |
|
|
2024
Q1 | $390M | Sell |
404,244
-30,156
| -7% | -$29.1M | 0.42% | 59 |
|
|
2023
Q4 | $382M | Buy |
434,400
+21,358
| +5% | +$18.8M | 0.42% | 58 |
|
|
2023
Q3 | $340M | Buy |
+413,042
| New | +$340M | 0.42% | 61 |
|